2026年 · 第42卷第02期

Trigeminal neuralgia is a common cranial nerve disease, usually confined to one or more branches of the unilateral trigeminal nerve distribution area, characterized by recurrent, transient electroshock-like, knife-like, needle-like pain, lasting from seconds to minutes, with abrupt onset and termination, induced by harmless stimulation within the trigeminal nerve distribution area^[1,2,3,4,5]。

central retinal artery occlusion (CRAO) refers to an acute disease in which the central retinal artery (CRA) is partially or completely occluded, causing sudden blindness or sudden vision decline, and significantly increasing the risk of acute ischemic events (such as ischemic stroke, acute myocardial infarction), death, and ocular neovascularization^[1,2]。 Among them, non-arteritis CRAO accounts for 95%, and this type of CRAO is mainly discussed in the Expert Consensus on Neurointervention of Central Retinal Artery Occlusion (2026 Edition) (hereinafter referred to as this consensus). Studies have shown that retinal ischemia can cause irreversible damage for up to 105~240 min^[3]It suggests the importance of early diagnosis and treatment. CRAO is regarded as a special type of acute ischemic stroke, and conservative treatments such as eye massage and medication usually fail to significantly improve vision. intra-arterial thrombolysis (IAT) technique can quickly restore blood perfusion by superselective perfusion of drugs into the ophthalmic artery through microcatheters. However, there is no uniform standard and different conclusions in the evaluation of efficacy at present. This consensus combines the latest clinical research and expert experience to provide a reference for the endovascular treatment of CRAO.